{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T12:37:00Z","timestamp":1786538220851,"version":"build-2736575974"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T00:00:00Z","timestamp":1663718400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073004, 81602390"],"award-info":[{"award-number":["82073004, 81602390"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017691","name":"Guangxi Key Research and Development Program","doi-asserted-by":"publisher","award":["GuiKe-AB18050011"],"award-info":[{"award-number":["GuiKe-AB18050011"]}],"id":[{"id":"10.13039\/501100017691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011785","name":"Science and Technology Department of Guangxi Zhuang Autonomous","doi-asserted-by":"publisher","award":["GuiKe-AD20297069"],"award-info":[{"award-number":["GuiKe-AD20297069"]}],"id":[{"id":"10.13039\/501100011785","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Liquid biopsy facilitates the enrichment and isolation of circulating tumor cells (CTCs) in various human cancers, including nasopharyngeal carcinoma (NPC). Characterizing CTCs allows observation of the evolutionary process of single tumor cells undergoing blood-borne dissemination, such as epithelial-mesenchymal transition. However, the prognostic value of phenotypic classification of CTCs in predicting the clinical outcomes of NPC remains poorly understood.<\/jats:p><\/jats:sec><jats:sec><jats:title>Patients and methods<\/jats:title><jats:p>A total of 92 patients who met the inclusion criteria were enrolled in the present study. The CanPatrol\u2122 CTC technology platform was employed to isolate CTCs, and an RNA <jats:italic>in situ<\/jats:italic> hybridization-based system was used for phenotypic classification. Kaplan\u2013Meier survival curves were used for univariate survival analysis, and the log-rank test was performed for between-group comparisons of the survival curves.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>CTCs were detected in 88.0% (81\/92) of the enrolled patients with NPC. The total CTC number did not vary between the T and N stages or between Epstein\u2013Barr virus DNA-positive and -negative cases. The numbers of total CTCs and epithelial\/mesenchymal (E\/M) hybrid CTCs decreased significantly at 3 months post concurrent chemoradiotherapy (<jats:italic>P<\/jats:italic>=0.008 and <jats:italic>P<\/jats:italic>=0.023, respectively), whereas the numbers of epithelial or mesenchymal CTCs did not decrease. E\/M hybrid-predominant cases had lower disease-free survival (<jats:italic>P<\/jats:italic>=0.043) and distant metastasis-free survival (<jats:italic>P<\/jats:italic>=0.046) rates than non-E\/M hybrid-predominant cases.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>CTC classification enables a better understanding of the cellular phenotypic alterations responsible for locoregional invasion and distant metastasis in NPC. E\/M hybrid-predominant CTC distribution predicts unfavorable clinical outcomes in patients with progressive NPC.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2022.988458","type":"journal-article","created":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T05:03:57Z","timestamp":1663736637000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Epithelial-mesenchymal transition classification of circulating tumor cells predicts clinical outcomes in progressive nasopharyngeal carcinoma"],"prefix":"10.3389","volume":"12","author":[{"given":"Jiazhang","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiming","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjin","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiping","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linsong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huashuang","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunzhong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sifang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenhong","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00055-0","article-title":"Nasopharyngeal carcinoma","volume":"387","author":"Chua","year":"2016","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","article-title":"Nasopharyngeal carcinoma","volume":"394","author":"Chen","year":"2019","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1462399407000312","article-title":"Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments","volume":"9","author":"Tao","year":"2007","journal-title":"Expert Rev Mol Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s40880-017-0257-9","article-title":"Nasopharyngeal carcinoma incidence and mortality in China, 2013","volume":"36","author":"Wei","year":"2017","journal-title":"Chin J Cancer"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.soc.2015.03.008","article-title":"Nasopharyngeal carcinoma","volume":"24","author":"Kamran","year":"2015","journal-title":"Surg Oncol Clin N Am"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-021-00524-x","article-title":"Nasopharyngeal carcinoma: an evolving paradigm","volume":"18","author":"Wong","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201010021","article-title":"Circulating tumor cells: approaches to isolation and characterization","volume":"192","author":"Yu","year":"2011","journal-title":"J Cell Biol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2012.194258","article-title":"Circulating tumor cells: liquid biopsy of cancer","volume":"59","author":"Alix-Panabi\u00e8res","year":"2013","journal-title":"Clin Chem"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1126\/science.1228522","article-title":"Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition","volume":"339","author":"Yu","year":"2013","journal-title":"Science"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/nature11217","article-title":"RNA Sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis","volume":"487","author":"Yu","year":"2012","journal-title":"Nature"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.6452\/KJMS.200001.0001","article-title":"Detection of circulating tumor cells in venous blood of nasopharyngeal carcinoma patients by nested reverse transcriptase-polymerase chain reaction","volume":"16","author":"Lin","year":"2000","journal-title":"Kaohsiung J Med Sci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyw046","article-title":"Distribution and clinical significance of circulating tumor cells in nasopharyngeal carcinoma","volume":"46","author":"Si","year":"2016","journal-title":"Jpn J Clin Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2017.1281493","article-title":"The association between circulating tumor cells and Epstein-Barr virus activation in patients with nasopharyngeal carcinoma","volume":"18","author":"He","year":"2017","journal-title":"Cancer Biol Ther"},{"key":"B14","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1186\/s12885-017-3471-6","article-title":"Joint quantitative measurement of hTERT mRNA in both peripheral blood and circulating tumor cells of patients with nasopharyngeal carcinoma and its clinical significance","volume":"17","author":"Fu","year":"2017","journal-title":"BMC Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.radonc.2018.07.022","article-title":"The prognostic value of COX-2 expression on circulating tumor cells in nasopharyngeal carcinoma: A prospective analysis","volume":"129","author":"Li","year":"2018","journal-title":"Radiother Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_201908_18735","article-title":"Clinical significance of circulating tumor cells and their expression of cyclooxygenase-2 in patients with nasopharyngeal carcinoma","volume":"23","author":"Xie","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1177\/1533033820909911","article-title":"Circulating tumor cells and fibronectin 1 in the prognosis of nasopharyngeal carcinoma","volume":"19","author":"Yu","year":"2020","journal-title":"Technol Cancer Res Treat"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083135","article-title":"Molecular characterization and clinical implications of spindle cells in nasopharyngeal carcinoma: a novel molecule-morphology model of tumor progression proposed","volume":"8","author":"Luo","year":"2013","journal-title":"PloS One"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.21037\/tcr-19-2899","article-title":"Comparison of whole exome sequencing in circulating tumor cells of primitive and metastatic nasopharyngeal carcinoma","volume":"9","author":"Si","year":"2020","journal-title":"Transl Cancer Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/hed.27006","article-title":"Prognostic value of hypothyroidism in patients undergoing intensity-modulated radiation therapy for nasopharyngeal carcinoma","volume":"44","author":"Weng","year":"2022","journal-title":"Head Neck"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S262567","article-title":"Effects of surgery combined with chemoradiotherapy on short- and long-term outcomes of early-stage nasopharyngeal carcinoma","volume":"12","author":"Weng","year":"2020","journal-title":"Cancer Manag Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2013-0558","article-title":"Enrichment and enumeration of circulating tumor cells by efficient depletion of leukocyte fractions","volume":"52","author":"Wu","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123976","article-title":"Classification of circulating tumor cells by epithelial-mesenchymal transition markers","volume":"10","author":"Wu","year":"2015","journal-title":"PloS One"},{"key":"B24","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12957-018-1423-5","article-title":"A study on the value of narrow-band imaging (NBI) for the general investigation of a high-risk population of nasopharyngeal carcinoma (NPC)","volume":"16","author":"Si","year":"2018","journal-title":"World J Surg Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.07.013","article-title":"Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis","volume":"158","author":"Aceto","year":"2014","journal-title":"Cell"},{"key":"B26","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.cell.2018.11.046","article-title":"Circulating tumor cell clustering shapes DNA methylation to enable metastasis seeding","volume":"176","author":"Gkountela","year":"2019","journal-title":"Cell"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1126\/science.1253533","article-title":"Cancer therapy. ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility","volume":"345","author":"Yu","year":"2014","journal-title":"Science"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.954848","article-title":"Analysis and experimental validation of rheumatoid arthritis innate immunity gene CYFIP2 and pan-cancer","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41419-022-04506-4","article-title":"Cancer-derived exosomal HSPC111 promotes colorectal cancer liver metastasis by reprogramming lipid metabolism in cancer-associated fibroblasts","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1038\/s41467-022-29884-3","article-title":"ZNF117 regulates glioblastoma stem cell differentiation towards oligodendroglial lineage","volume":"13","author":"Liu","year":"2022","journal-title":"Nat Commun"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/genes12091448","article-title":"Whole-genome profiles of Malay colorectal cancer patients with intact MMR proteins","volume":"12","author":"Juhari","year":"2021","journal-title":"Genes (Basel)"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-19-0887","article-title":"Whole exome sequencing of highly aggregated lung cancer families reveals linked loci for increased cancer risk on chromosomes 12q, 7p, and 4q","volume":"29","author":"Musolf","year":"2020","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1186\/s12885-018-5034-x","article-title":"Circulating tumor cells with karyotyping as a novel biomarker for diagnosis and treatment of nasopharyngeal carcinoma","volume":"18","author":"Zhang","year":"2018","journal-title":"BMC Cancer"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2019.10560","article-title":"Detection and clinical significance of circulating tumor cells in patients with nasopharyngeal carcinoma","volume":"18","author":"Wen","year":"2019","journal-title":"Oncol Lett"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-019-00777-z","article-title":"Association of plasma Epstein-Barr virus LMP1 and EBER1 with circulating tumor cells and the metastasis of nasopharyngeal carcinoma","volume":"26","author":"Sun","year":"2020","journal-title":"Pathol Oncol Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-020-0871-1","article-title":"Clinical utility of serial analysis of circulating tumour cells for detection of minimal residual disease of metastatic nasopharyngeal carcinoma","volume":"123","author":"Ko","year":"2020","journal-title":"Br J Cancer"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12100","article-title":"Clinical utility of Epstein-Barr virus DNA and other liquid biopsy markers in nasopharyngeal carcinoma","volume":"40","author":"Tan","year":"2020","journal-title":"Cancer Commun (Lond)"},{"key":"B38","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s10020-019-0112-3","article-title":"Circulating tumor cells: a valuable marker of poor prognosis for advanced nasopharyngeal carcinoma","volume":"25","author":"Ou","year":"2019","journal-title":"Mol Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32380","article-title":"Relationship of circulating tumor cells and Epstein-Barr virus DNA to progression-free survival and overall survival in metastatic nasopharyngeal carcinoma patients","volume":"145","author":"You","year":"2019","journal-title":"Int J Cancer"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2892","article-title":"Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer","volume":"32","author":"Lohr","year":"2014","journal-title":"Nat Biotechnol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.cell.2011.11.016","article-title":"Cancer invasion and the microenvironment: plasticity and reciprocity","volume":"147","author":"Friedl","year":"2011","journal-title":"Cell"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B43","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: New dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discovery"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"J\u00a0Clin Invest"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2620","article-title":"Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits","volume":"9","author":"Polyak","year":"2009","journal-title":"Nat Rev Cancer"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.988458\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T05:04:03Z","timestamp":1663736643000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.988458\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,21]]},"references-count":45,"alternative-id":["10.3389\/fonc.2022.988458"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.988458","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,21]]},"article-number":"988458"}}